There is little time left for Sonnet BioTherapeutics Holdings Inc. (SONN) to reach its 1-year target estimate. How soon will it surpass it?

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) shares traded 6.14% higher at $4.67 on Wall Street last session. In accordance with the data, 3 analysts cover Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $100.00 and a low […]

The most important numbers to know about Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN)

Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) shares traded -8.71% lower at $0.35 on Wall Street last session. In accordance with the data, 3 analysts cover Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $12.00 and a low […]